Safety and efficacy of canakinumab in Japanese patients with phenotypes of cryopyrin-associated periodic syndrome as established in the first open-label, phase-3 pivotal study (24-week results).
Year: 2013
Type: article
Study design: Clinical Trial
Source: PubMed
Institutions: Yokohama City University, Kyoto University, Kyushu University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2731378
